Major ligand-induced rearrangement of the heptahelical domain interface in a GPCR dimer

2014 ◽  
Vol 11 (2) ◽  
pp. 134-140 ◽  
Author(s):  
Li Xue ◽  
Xavier Rovira ◽  
Pauline Scholler ◽  
Han Zhao ◽  
Jianfeng Liu ◽  
...  
Keyword(s):  
2019 ◽  
Vol 20 (12) ◽  
pp. 2958 ◽  
Author(s):  
Wouters ◽  
Vasudevan ◽  
Crans ◽  
Saini ◽  
Stove

G protein-coupled receptors (GPCRs) have the propensity to form homo- and heterodimers. Dysfunction of these dimers has been associated with multiple diseases, e.g., pre-eclampsia, schizophrenia, and depression, among others. Over the past two decades, considerable efforts have been made towards the development of screening assays for studying these GPCR dimer complexes in living cells. As a first step, a robust in vitro assay in an overexpression system is essential to identify and characterize specific GPCR–GPCR interactions, followed by methodologies to demonstrate association at endogenous levels and eventually in vivo. This review focuses on protein complementation assays (PCAs) which have been utilized to study GPCR oligomerization. These approaches are typically fluorescence- and luminescence-based, making identification and localization of protein–protein interactions feasible. The GPCRs of interest are fused to complementary fluorescent or luminescent fragments that, upon GPCR di- or oligomerization, may reconstitute to a functional reporter, of which the activity can be measured. Various protein complementation assays have the disadvantage that the interaction between the reconstituted split fragments is irreversible, which can lead to false positive read-outs. Reversible systems offer several advantages, as they do not only allow to follow the kinetics of GPCR–GPCR interactions, but also allow evaluation of receptor complex modulation by ligands (either agonists or antagonists). Protein complementation assays may be used for high throughput screenings as well, which is highly relevant given the growing interest and effort to identify small molecule drugs that could potentially target disease-relevant dimers. In addition to providing an overview on how PCAs have allowed to gain better insights into GPCR–GPCR interactions, this review also aims at providing practical guidance on how to perform PCA-based assays.


eLife ◽  
2017 ◽  
Vol 6 ◽  
Author(s):  
Junke Liu ◽  
Zongyong Zhang ◽  
David Moreno-Delgado ◽  
James AR Dalton ◽  
Xavier Rovira ◽  
...  

GPCRs play critical roles in cell communication. Although GPCRs can form heteromers, their role in signaling remains elusive. Here we used rat metabotropic glutamate (mGlu) receptors as prototypical dimers to study the functional interaction between each subunit. mGluRs can form both constitutive homo- and heterodimers. Whereas both mGlu2 and mGlu4 couple to G proteins, G protein activation is mediated by mGlu4 heptahelical domain (HD) exclusively in mGlu2-4 heterodimers. Such asymmetric transduction results from the action of both the dimeric extracellular domain, and an allosteric activation by the partially-activated non-functional mGlu2 HD. G proteins activation by mGlu2 HD occurs if either the mGlu2 HD is occupied by a positive allosteric modulator or if mGlu4 HD is inhibited by a negative modulator. These data revealed an oriented asymmetry in mGlu heterodimers that can be controlled with allosteric modulators. They provide new insight on the allosteric interaction between subunits in a GPCR dimer.


2019 ◽  
Author(s):  
Adrián García-Recio ◽  
Gemma Navarro ◽  
Rafael Franco ◽  
Mireia Olivella ◽  
Ramon Guixà-González ◽  
...  

AbstractG protein-coupled receptors (GPCRs) can form homo-, heterodimers and larger order oligomers that exert different functions than monomers. The pharmacological potential of such complexes is hampered by the limited information available on the type of complex formed and its quaternary structure. Several GPCR structures in the Protein Data Bank display crystallographic interfaces potentially compatible with physiological interactions. Here we present DIMERBOW, a database and web application aimed to visually browse the complete repertoire of potential GPCR dimers present in solved structures. The tool is suited to help finding the best possible structural template to model GPCR homomers. DIMERBOW is available at http://lmc.uab.es/dimerbow/.


2006 ◽  
Vol 25 (24) ◽  
pp. 5693-5702 ◽  
Author(s):  
Marjorie Damian ◽  
Aimée Martin ◽  
Danielle Mesnier ◽  
Jean-Philippe Pin ◽  
Jean-Louis Banères

2018 ◽  
Vol 9 ◽  
Author(s):  
Dasiel O. Borroto-Escuela ◽  
David Rodriguez ◽  
Wilber Romero-Fernandez ◽  
Jon Kapla ◽  
Mariama Jaiteh ◽  
...  

2020 ◽  
Vol 36 (10) ◽  
pp. 3271-3272 ◽  
Author(s):  
Adrián García-Recio ◽  
Gemma Navarro ◽  
Rafael Franco ◽  
Mireia Olivella ◽  
Ramon Guixà-González ◽  
...  

Abstract Motivation G protein-coupled receptors (GPCRs) can form homo-, heterodimers and larger order oligomers that exert different functions than monomers. The pharmacological potential of such complexes is hampered by the limited information available on the type of complex formed and its quaternary structure. Several GPCR structures in the Protein Data Bank display crystallographic interfaces potentially compatible with physiological interactions. Results Here, we present DIMERBOW, a database and web application aimed to visually browse the complete repertoire of potential GPCR dimers present in solved structures. The tool is suited to help finding the best possible structural template to model GPCR homomers. Availability and implementation DIMERBOW is available at http://lmc.uab.es/dimerbow/. Supplementary information Supplementary data are available at Bioinformatics online.


2018 ◽  
Vol 20 (19) ◽  
pp. 13485-13496 ◽  
Author(s):  
Xi Zhang ◽  
Yuan Yuan ◽  
Longrong Wang ◽  
Yanzhi Guo ◽  
Menglong Li ◽  
...  

Using multiscale simulation to explore the activation of a GPCR dimer.


Sign in / Sign up

Export Citation Format

Share Document